Lanean...
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art
PURPOSE OF REVIEW: We aim to summarize the current state of art about the possible use of biomarkers for predicting renal cell carcinoma (RCC) recurrence after curative treatment. In addition, we aim to provide a snapshot about the clinical implication of biomarkers use for follow-up planification....
Gorde:
| Argitaratua izan da: | Curr Urol Rep |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8062344/ https://ncbi.nlm.nih.gov/pubmed/33886004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11934-021-01050-0 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|